Bacterial strains capable of metabolizing oxalates

Abstract

A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.

1 .- 5 . (canceled) 
     
     
         6 . A food composition or supplement product or medical device or pharmaceutical composition comprising at least one bacterial strain  L. paracasei  spp.  paracasei  LPC 09 DSM 24243 and a fibre selected from the group consisting of fructo-oligosaccharides (FOS), inulin, xylo-oligosaccharides (XOS), and galacto-oligosaccharides with galactose residual (GOS-Gal in an effective amount for preventive and/or curative treatment of at least one of hyperoxaluria, urolithiasis, kidney failure, cardiopathies, kidney stones, diverticulosis and diverticulitis. 
     
     
         7 . (canceled) 
     
     
         8 . The food composition or supplement product or medical device or pharmaceutical composition according to  claim 6 , wherein said bacterial composition further comprises the bacterial strain  L. gasseri  LGS 01 DSM 18299 and the bacterial strain  L. gasseri  LGS 02 DSM 18300. 
     
     
         9 . The food composition or supplement product or medical device or pharmaceutical composition according to  claim 6 , wherein said bacterial composition further comprises the bacterial strain  L. acidophilus  LA02 DSM 21717 and the bacterial strain  L. acidophilus  LA 07 DSM 24303. 
     
     
         10 . The food composition or supplement product or medical device or pharmaceutical composition according to  claim 6 , wherein said bacterial composition consists of  L. paracasei  spp.  paracasei  LPC 09 DSM 24243 , L. acidophilus  LA02 DSM 21717 and  L. acidophilus  LA 07 DSM 24303. 
     
     
         11 . The food composition or supplement product or medical device or pharmaceutical composition according to  claim 6 , wherein said fibre comprises fructo-oligosaccharides and inulin. 
     
     
         12 . The food composition or supplement product or medical device or pharmaceutical composition according to  claim 6 , wherein the fructo-oligosaccharides and inulin are comprised in an amount from 3 to 15%, by weight. 
     
     
         13 . The food composition or supplement product or medical device or pharmaceutical composition according to  claim 6 , wherein the fructo-oligosaccharides and inulin are comprised in an amount from 5 to 10% by weight.